Study of Dextromethorphan in OCD and Related Disorders (NCT04899687)

🧪 Interventions in This Study

• Fluoxetine (DRUG)
• Dextromethorphan (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Stanford University — Stanford, California

📞 Contact the Study Coordinator

Phone: (650) 497-2578

Email: ocdresearch@stanford.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Obsessive-Compulsive Disorder

• Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD — Toronto, Ontario
• Effects of Psilocybin in Obsessive Compulsive Disorder — Baltimore, Maryland
• Development of Adaptive Deep Brain Stimulation for OCD — Pittsburgh, Pennsylvania
• Phase II Adaptive Deep Brain Stimulation for Obsessive-Compulsive Disorder — Pittsburgh, Pennsylvania
• Personalized DBS for OCD Guided by Stereoencephalography Mapping — San Francisco, California
• Brain Recordings in Patients Undergoing Deep Brain Stimulation (DBS) for Severe Obsessive-Compulsive Disorder (OCD) — Houston, Texas

Explore by condition: All Obsessive-Compulsive Disorder clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.